Literature DB >> 17785281

Caspofungin in vitro and in vivo activity against Brazilian Pythium insidiosum strains isolated from animals.

Daniela Isabel Brayer Pereira1, Janio Morais Santurio, Sydney Hartz Alves, Juliana Siqueira Argenta, Luciana Pötter, Andréia Spanamberg, Laerte Ferreiro.   

Abstract

OBJECTIVES: The present study evaluated the susceptibility of 27 clinical isolates of Pythium insidiosum to caspofungin in vitro and correlated the results with the therapeutic response in vivo in rabbits with experimental pythiosis.
METHODS: The macrodilution method was performed in accordance with the CLSI document M38-A technique. Three reading criteria for MICs were adopted: MIC0, MIC1 and MIC2 (100%, 90% and 50% growth inhibition, respectively). The minimum fungicidal concentration was also determined. Ten rabbits inoculated with viable P. insidiosum zoospores were divided into two groups: group 1 (control) and group 2 (treated with caspofungin at a dosage of 1 mg/kg/day for 20 consecutive days).
RESULTS: Of the isolates 51.8% had an MIC0 of 64 mg/L, 88.8% of isolates had an MIC1 between 8 and 64 mg/L and 62.9% of isolates had a minimum fungicidal concentration of 64 mg/L. In the in vivo assay, growth of subcutaneous lesions reduced during treatment, but rapidly resumed when treatment was stopped.
CONCLUSIONS: The results showed that caspofungin has limited fungistatic activity against P. insidiosum. This work is the first study to analyse the susceptibility of this oomycete to inhibitors of beta-glucans of the cellular wall.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17785281     DOI: 10.1093/jac/dkm332

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  21 in total

1.  In Vitro Activities of Miltefosine and Antibacterial Agents from the Macrolide, Oxazolidinone, and Pleuromutilin Classes against Pythium insidiosum and Pythium aphanidermatum.

Authors:  Erico S Loreto; Juliana S M Tondolo; Daniele C Oliveira; Janio M Santurio; Sydney H Alves
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  Combat-Related Pythium aphanidermatum Invasive Wound Infection: Case Report and Discussion of Utility of Molecular Diagnostics.

Authors:  Aaron R Farmer; Clinton K Murray; Ian R Driscoll; Brian L Wickes; Nathan Wiederhold; Deanna A Sutton; Carmita Sanders; Katrin Mende; Brent Enniss; James Feig; Anuradha Ganesan; Elizabeth A Rini; Todd J Vento
Journal:  J Clin Microbiol       Date:  2015-04-01       Impact factor: 5.948

3.  In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.

Authors:  Juliana S Argenta; Janio M Santurio; Sydney H Alves; Daniela I B Pereira; Ayrton S Cavalheiro; Andréia Spanamberg; Laerte Ferreiro
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

4.  In Vitro activity of terbinafine combined with caspofungin and azoles against Pythium insidiosum.

Authors:  Ayrton S Cavalheiro; Grazieli Maboni; Maria I de Azevedo; Juliana S Argenta; Daniela I B Pereira; Tatiana B Spader; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

5.  In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum.

Authors:  Francielli P K Jesus; Laerte Ferreiro; Érico S Loreto; Maiara B Pilotto; Aline Ludwig; Karine Bizzi; Juliana S M Tondolo; Régis A Zanette; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2014-07-07       Impact factor: 5.191

6.  New insights into the in vitro susceptibility of Pythium insidiosum.

Authors:  Erico S Loreto; Juliana S M Tondolo; Maiara B Pilotto; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

7.  In vitro susceptibility of Pythium insidiosum isolates to aminoglycoside antibiotics and tigecycline.

Authors:  Deise Luiza Mahl; Francielli Pantella Kunz de Jesus; Érico Silva Loreto; Régis Adriel Zanette; Laerte Ferreiro; Maiara Ben Pilotto; Sydney Hartz Alves; Janio Morais Santurio
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

8.  In vitro susceptibility of Brazilian Pythium insidiosum isolates to essential oils of some Lamiaceae family species.

Authors:  A O S Fonseca; D I B Pereira; R G Jacob; F S Maia Filho; D H Oliveira; B P Maroneze; J S S Valente; L G Osório; S A Botton; M C A Meireles
Journal:  Mycopathologia       Date:  2014-11-28       Impact factor: 2.574

9.  The 74-kilodalton immunodominant antigen of the pathogenic oomycete Pythium insidiosum is a putative exo-1,3-beta-glucanase.

Authors:  Theerapong Krajaejun; Angsana Keeratijarut; Kanchana Sriwanichrak; Tassanee Lowhnoo; Thidarat Rujirawat; Thanom Petchthong; Wanta Yingyong; Thareerat Kalambaheti; Nat Smittipat; Tada Juthayothin; Thomas D Sullivan
Journal:  Clin Vaccine Immunol       Date:  2010-03-17

10.  In Vitro Susceptibility of Pythium insidiosum to Melaleuca alternifolia, Mentha piperita and Origanum vulgare Essential Oils Combinations.

Authors:  Júlia de Souza Silveira Valente; Anelise de Oliveira da Silva Fonseca; Laura Bedin Denardi; Vanessa Silveira Dal Ben; Fernando de Souza Maia Filho; Cristiane Telles Baptista; Caroline Quintana Braga; Cristina Gomes Zambrano; Sydney Hartz Alves; Sônia de Avila Botton; Daniela Isabel Brayer Pereira
Journal:  Mycopathologia       Date:  2016-05-21       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.